BioRestorative Therapies files registration statement of Form S-1

BioRestorative Therapies announced the filing of a registration statement on Form S-1 with the SEC. The registration statement solely covers the resale by selling securityholders of up to 2,513,686 shares of common stock of the company that are issuable pursuant to the exercise of previously issued warrants. The filing was made pursuant to registration rights granted to the selling securityholders in connection with the issuance of the warrants to them.